Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      NOT_YET_RECRUITING
      Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS])
      Description

      The primary objective of this study is to assess the safety and tolerability of BPN14770 in participants aged 9 to 45 years with JS.

      Conditions
      Jordan's SyndromePPP2R5D Neurodevelopmental Disorder
      Talk to us